Table 2 CIN1 and CIN2+ (percentage) in the HPV genotypes 16, 18, 31, 33 and 45
From: HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women
HPV | N° | No atypia | CIN1 | CIN2+ |
|---|---|---|---|---|
HPV16 | 404 (59.9%) | 94 (23.3%) | 130 (33.2%) | 180 (44.6%) |
HPV31 | 116 (17.2%) | 40 (34.5%) | 56 (48.3%) | 20 (17.2%) |
HPV18 | 98 (14.5%) | 20 (20.4%) | 64 (65.3%) | 14(14.3%) |
HPV33 | 35 (5.2%) | 5 (14.6%) | 26 (74.3%) | 4 (11.4%) |
HPV45 | 21 (3.1%) | 3 (14.3%) | 16 (76.2%) | 2 (9.5%) |
total | 674 | 162 | 292 | 220 |